| Bioactivity | PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1) is a matrix materia, with lactic acid (LA)：glycolic acid (GA) = 1:1, that acts as anti-cancer drug delivery. PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1) can improve a drug's bioavailability, efficacy, water solubility, drug encapsulation efficiency, sustained drug release, and to minimize undesirable toxicity[1]. |
| Name | PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1) |
| Molar Mass | Average Mn (1500-1500-1500) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xiufen Chen, et al. PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment. J Colloid Interface Sci. 2017 Mar 15:490:542-552. [2]. Yuan Gao, et al. A thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of docetaxel. J Drug Target. 2011 Aug;19(7):516-27. |
PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1)
CAS: F: W: Average Mn (1500-1500-1500)
PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1) is a matrix materia, with lactic acid (LA)：glycolic acid (GA) = 1:1, that ac
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.